Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03484923
Title Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma (PLATforM)
Acronym PLATforM
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
UCSF Medical Center . San Francisco California 94143 United States Details
Massachusetts General Hospital Massachusetts Gen. Hospital CC Boston Massachusetts 02114 United States Details
NYU Laura and Isaac Perlmutter Cancer Center Perlmutter Cancer Center New York New York 10016 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Novartis Investigative Site North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Marseille 13009 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Muenchen 81377 Germany Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Rotterdam 3015 GD Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Zuerich 8091 Switzerland Details
Novartis Investigative Site Northwood Middlesex HA6 2RN United Kingdom Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field